TP1001(Shengyuan Zetong)

Primary Objective: To evaluate the safety and tolerability of single or multiple oral administrations of TP1001 tablets in healthy Chinese participants. Secondary Objectives: 1. To evaluate the pharmacokinetic characteristics of single or multiple oral administrations of TP1001 tablets in healthy Chinese participants; 2. To evaluate the pharmacokinetic effects of food on single oral administration of TP1001 tablets in healthy Chinese participants; 3. To evaluate the effect of TP1001 concentration on the QT/QTC interval after a single oral administration of TP1001 tablets in healthy Chinese participants. Exploratory Objectives: 1. To explore the possible metabolites and metabolic pathways after a single oral administration of TP1001 tablets in healthy Chinese participants; 2. To explore potential target engagement biomarkers after a single oral administration of TP1001 tablets in healthy Chinese participants.